Risk factors for metastatic uveal melanoma after trans-scleral local resection

被引:52
作者
Damato, BE
Paul, J
Foulds, WS
机构
[1] UNIV GLASGOW,WESTERN INFIRM,TENNENT INST OPHTHALMOL,GLASGOW G11 6NT,LANARK,SCOTLAND
[2] WESTERN INFIRM & ASSOCIATED HOSP,BEATSON ONCOL CTR,CLIN TRIALS UNIT,GLASGOW,LANARK,SCOTLAND
关键词
D O I
10.1136/bjo.80.2.109
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aims-This study reports the metastatic death rate after trans-scleral local resection of uveal melanoma and identifies relevant risk factors. Methods-Local resection was performed in 332 patients (mean. age 51 years), with follow up ranging to 20.9 years (median for living patients 33 months). The tumours had a mean largest basal diameter of 13.1 mm and mean thickness of 7.5 mm, with 135 containing epithelioid cells. Risk factors were identified by Cox analysis and metastatic rates demonstrated using Kaplan-Meier curves. Results-There were 52 deaths from metastatic melanoma. The significant risk factors were (i) age more than 60 years at treatment (p=0.001), (ii) mixed/epithelioid tumours (p=0.003), (iii) superior location of mixed/epithelioid tumours (over and above (ii)) (p=0.001), (iv) largest basal tumour diameter of 16 mm or more (p<0.001), (v) lack of adjunctive radiotherapy (p=0.031), (vi) secondary enucleation for bulky residual/recurrent tumour (p=0.002), and (vii) secondary enucleation for small residual/recurrent tumour extraocularly (p=0.019). Metastatic death was not significantly associated with (i) incomplete tumour excision (p=0.163), and (ii) small residual/recurrent tumour treated by enucleation (p=0.855). Conclusions-Survival diminished from 92% at 15 years if less than two risk factors were present to less than 30% in 3.5 years if more than three risk factors were present.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 45 条
[1]   CHANGES IN HEIGHT OF CHOROIDAL MELANOMAS AFTER PLAQUE THERAPY [J].
ABRAMSON, DH ;
SERVODIDIO, CA ;
MCCORMICK, B ;
FASS, D ;
ZANG, E .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1990, 74 (06) :359-362
[2]  
AFFELDT JC, 1980, ARCH OPHTHALMOL-CHIC, V98, P1975
[3]  
ARMITAGE P, 1987, STATISTICAL METHODS
[4]  
AUGSBURGER JJ, 1987, OPHTHALMOLOGY, V94, P1173
[5]   CO-60 PLAQUE RADIOTHERAPY VS ENUCLEATION FOR POSTERIOR UVEAL MELANOMA [J].
AUGSBURGER, JJ ;
GAMEL, JW ;
LAURITZEN, K ;
BRADY, LW .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1990, 109 (05) :585-592
[6]  
BORNFELD N, 1991, TUMORS EYE, P419
[7]   5-YEAR FOLLOW-UP OF HELIUM ION THERAPY FOR UVEAL MELANOMA [J].
CHAR, DH ;
CASTRO, JR ;
KROLL, SM ;
IRVINE, AR ;
QUIVEY, JM ;
STONE, RD .
ARCHIVES OF OPHTHALMOLOGY, 1990, 108 (02) :209-214
[8]  
CHAR DH, 1993, OPHTHALMOLOGY, V100, P1547
[9]   FAILURE OF PREENUCLEATION RADIATION TO DECREASE UVEAL MELANOMA MORTALITY [J].
CHAR, DH ;
PHILLIPS, TL ;
ANDEJESKI, Y ;
CRAWFORD, JB ;
KROLL, S .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1988, 106 (01) :21-26
[10]   METASTATIC CHOROIDAL MELANOMA [J].
CHAR, DH .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1978, 86 (01) :76-80